Mersana Therapeutics Inc

MRSN

Get informed when a big investor buys or sells

Market Cap$145.36M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Mersana Therapeutics Inc	-2.1	-	118%	4.8	-0.4

$-1.14

Current Fair Value

103.9% downside

Overvalued by 103.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$145.36 Million
Enterprise Value	$115.04 Million
Dividend Yield	$- (-)
Earnings per Share	$-14.12
Beta	0.43
Outstanding Shares	4,986,784

Return

Return on Equity	117.71%
Return on Assets	-111.80%
Return on Invested Capital	-309.96%

Valuation & Multiples

P/E Ratio	-2.07
PEG	6.02
Price to Sales	4.85
Price to Book Ratio	-2.42
Enterprise Value to Revenue	3.47
Enterprise Value to EBIT	-1.91
Enterprise Value to Net Income	-2
Total Debt to Enterprise	0.23
Debt to Equity	-0.44

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

March 2, 2026

EPS Estimate

$-3.05

Average shareholder expectation

Revenue Estimate

$4.60 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.00000%
Total Calls	30,400▲ Infinity%
Total Puts	-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	45.01%▼ 18.73%
Total Invested	$64.77M▲ 162.65%
Investors Holding	50▲ 1.00%

ESG Score